Search for Studies
Search Results
The Continence, Sexual and Metabolic Health (CONTROL 4 LIFE) study will evaluate the recovery of continence, sexual function, and health outcomes in individuals who have undergone surgery for prostate cancer. The purpose of this study is to better understand the timelines of recovery for these outcomes after surgery for prostate cancer. As part of this study, all participants will receive resources offered by Alberta Health Services regarding pre- and post-prostatectomy care, including information on pelvic floor exercises. Through the CONTROL 4 LIFE study, the investigators will also be evaluating outcomes related to physical activity, fitness and quality of life. These assessments will enable the investigators to better understand how well and how long it takes for individuals to recover after surgery for prostate cancer.
Conditions:
Prostate Cancer | Metabolic Disease | IncontinenceLocation:
- University of Alberta, Edmonton, Alberta, Canada
Sex:
MALEAges:
Over 18The primary objective of this study is to: * Evaluate the safety and tolerability of AMG 305 in adult participants * Determine the optimal biologically active dose (OBD), at or below the maximum tolerated dose (MTD) with MTD 1 as the maximum tolerated starting dose and MTD 2 as the maximum tolerated target dose * Determine the recommended phase 2 dose (RP2D)
Conditions:
Advanced Solid TumorsLocation:
- Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Sex:
ALLAges:
18 - 100The primary purpose of this study is to see if individuals with Multiple Myeloma are able and interested in taking part in a tailored exercise program while undergoing their chemotherapy prior to a stem cell transplant. We also hope to learn if this type of program, along with a flexible delivery format (in-person and virtual), helps in maintaining or improving physical fitness, muscle mass and strength, and quality of life during chemotherapy.
Conditions:
Multiple Myeloma | Exercise | PrehabilitationLocation:
- University of Alberta/ Cross Cancer Institute, Edmonton, Alberta, Canada
Sex:
ALLAges:
Over 18The goal of this study is to understand the performance of an experimental blood test that aims to detect early tumors in patients with hereditary cancer syndromes. If this new blood test is accurate, it could be used to screen patients for cancer and allow for earlier cancer detection. The study will compare cancer detection rates between those receiving the new blood test and those receiving standard care, assess if the test leads to earlier cancer diagnosis, and evaluate its impact on patient outcomes. The study will also use questionnaires and interviews to understand how patients feel about the blood test, its incorporation into routine medical care, and perceptions of the medical value of test results. This research could lead to more effective and less invasive cancer screening for high-risk individuals.
Conditions:
Hereditary Cancer SyndromeLocation:
- The Hospital for Sick Children, Toronto, Ontario, Canada
- Jewish General Hospital, Montreal, Quebec, Canada
- IWK Health Centre, Halifax, Nova Scotia, Canada
- Women's College Hospital, Toronto, Ontario, Canada
- Eastern Health, St. John's, Newfoundland and Labrador, Canada
- University Health Network, Toronto, Ontario, Canada
- BC Cancer Agency, Vancouver, British Columbia, Canada
- Sinai Health System, Toronto, Ontario, Canada
Sex:
ALLAges:
Under 90This study is being done to answer the following question: What are the effects of a new drug or drugs on ovarian cancer? The pre-study screening may be done to test a sample of tissue for biomarkers to determine participation in the study.
Conditions:
Ovarian CancerLocation:
- BCCA - Vancouver, Vancouver, British Columbia, Canada
- The Jewish General Hospital, Montreal, Quebec, Canada
- BCCA - Kelowna, Kelowna, British Columbia, Canada
- CHUM-Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada
- University Health Network, Toronto, Ontario, Canada
- Odette Cancer Centre, Toronto, Ontario, Canada
Sex:
FEMALEAges:
Over 18Children with disabilities often access rehabilitation services to improve their abilities to participate in everyday activities. Goal-directed therapy is considered an important therapeutic strategy to achieve outcomes that are meaningful to families. Not a lot is known about the effects of goal setting on rehabilitation outcomes. Strategies to help children participate in the goal-setting process are rarely used in clinical practice. The aim of this project is to test the effects of a child-focussed goal setting approach, Enhancing Child Engagement in Goal Setting (ENGAGE), on therapy outcomes. Service use and the cost vs. benefits of the ENGAGE approach compared to usual practice will also be examined. Children with neurodevelopmental disabilities aged 5-12 years old (n=96) who access paediatric rehabilitation services at six rehabilitation sites will participate. Therapists (n=24) at participating sites in Alberta, Canada will be randomized into 1) the ENGAGE intervention group or 2) the usual therapy practice control group. Children will participate in the ENGAGE approach to goal setting or usual practice based on the allocation of their therapist. This study will determine if the ENGAGE approach to goal setting affects child goal performance, satisfaction with goal performance, functional abilities, participation, and parent and child quality of life. The investigators will also evaluate differences in parent and child quality of life in relation to parent costs (e.g., absenteeism, presenteeism, travel costs) and compare amount of therapy time between the two groups to see which approach is more cost-effective and efficient. After the study, children, parents and therapists will be asked to discuss aspects that influenced effective implementation of the ENGAGE approach. This study could provide evidence to improve meaningful child and family outcomes in paediatric rehabilitation and improve efficiency of paediatric rehabilitation services.
Conditions:
Cerebral Palsy | Autism Spectrum Disorder | Neurodevelopmental DisordersLocation:
- Centre for Autism Services Alberta, Edmonton, Alberta, Canada
- Children's Rehabilitation Services, Alberta Health Services, Camrose, Alberta, Canada
- Society for Treatment of Autism, Calgary, Alberta, Canada
- Children's Rehabilitation Services, Alberta Health Services, Red Deer, Alberta, Canada
- Renfrew Educational Services, Calgary, Alberta, Canada
- Children's Rehabilitation Services, Alberta Health Services, Grande Prairie, Alberta, Canada
Sex:
ALLAges:
5 - 12Emergency Departments (EDs) across Ontario are being inundated with unprecedented high patient volumes and a staffing shortage that directly impacts patient care and flow. An area of concern among EDs is the offload zone where patients are brought in by ambulance. EMS offload time is the time it takes paramedics to transfer a patient to the appropriate area within an emergency department and give hospital staff a summary of what concerns the patient is seeking care for. There are multiple factors that may delay this time, including limited staff in the offload area to complete the transfer process due to competing patient care responsibilities. The adaptive staffing model study will look to add a primary care paramedic (PCP) or a registered nurse (RN) in the offload zone during times of high ambulance volume (August to January) to help with patient care within the offload zone. This single-centered community hospital study will evaluate the benefits of having a PCP or RN, compared to the current model, on ambulance offload times, patient safety outcomes, patient treatment times, and staff well-being using three different models of staffing.
Conditions:
Emergency Medicine | Well-Being, PsychologicalLocation:
- Markham Stouffville Hospital, Markham, Ontario, Canada
Sex:
ALLAges:
AnyThis study plans to analyze the molecular and clinical mechanisms of the relationship between the GBA mutations and Parkinson's disease. This will be assessed through the use of advanced neuroimaging techniques called PET (positron emission tomography) to study the accumulation of the tau protein and the dysfunction of acetylcholine and dopamine in the brain of people with a mutation in the GBA gene, with and without Parkinson's disease. The ingestigators will also use a technology-based assessment to study the typing patterns as possible biomarkers of early motor dysfunctions.
Conditions:
Parkinson Disease | GBA Gene Mutation | Gaucher DiseaseLocation:
- Pacific Parkinson's Research Centre | University of British Columbia, Vancouver, British Columbia, Canada
Sex:
ALLAges:
18 - 80The goal of this randomized controlled trial is to learn if an outdoor science education intervention can improve primary school students' learning and well-being when compared to an indoor classroom-based science education intervention. The main questions it aims to answer are: * Will students who engage in outdoor science learning produce higher-quality observations of living organisms than students who receive instruction exclusively in an indoor, classroom-based context, when both groups are invited to make observations in an unfamiliar natural environment? * Does an outdoor education intervention embedded within the science curriculum contribute to children's connection to nature, eco-anxiety and stress? Participants will: * Receive a science education intervention 2h/week for a total of 5 weeks, either indoors or outdoors * Answer questionnaires before and after the intervention * Participate in a field day-trip after the intervention where they will be asked to observe living organisms.
Conditions:
Healthy ChildrenLocation:
- Greater Montreal area (Laval, Longueuil, Montreal), Montreal, Quebec, Canada
Sex:
ALLAges:
AnyThis is a multi-centre, investigator-initiated, two-arm, randomized trial to investigate the addition on androgen receptor pathway inhibitor to standard of care radiation and hormone therapy improve quality of life. Participants will either receive standard of care radiation and hormone (ADT) therapy (Arm 1) or standard of care radiation and hormone (ADT) therapy plus oral abiraterone for 8-9 months (Arm 3). Participants will be routinely follow-up in clinic or remotely for up to 5 years.
Conditions:
Metastatic Prostate CancerLocation:
- Sunnybrook Research Institute, Toronto, Ontartio, Canada
- Princess Margaret Cancer Center, Toronto, Ontario, Canada